SQ109

SQ109 is a drug undergoing development for treatment of tuberculosis. SQ109 showed activity against both drug susceptible and multi-drug-resistant tuberculosis bacteria, including extensively drug-resistant tuberculosis strains. SQ109 is a novel 1,2-ethylene diamine small molecule drug with unique mechanisms of action that are distinct from other antibiotics used for the treatment of tuberculosis (TB). Synthink is a most trusted source of SQ109 Degradation Impurity, SQ109 Genotoxic impurity, SQ109 Process Impurity, USP related compound, SQ109 Nitrosamine impurity, N-Nitroso impurity etc. which are listed on this page.